Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Barak

Showing results (21-30 of 148) with videos related to

Pageof 15
Sort By:
Journal of Hematotherapy|January 1, 1994
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2aA Nagler, A Ackerstein, V Barak, et al.
Cytokines, Cellular & Molecular Therapy|November 24, 1998
Dysregulation of inflammatory cytokines in unrelated bone marrow transplantationA Nagler, A Bishara, C Brautbar, et al.
The Annals of Otology, Rhinology, and Laryngology|August 26, 1998
Cytokine evaluation in throat infectionsE Deutsch, M Kaufman, B Nisman, et al.
Harefuah|January 15, 1991
[Clinical applicability of intraperitoneal administration of nutrients and drugs]I Roisman, Z Gimon, V Barak, et al.
Israel Journal of Medical Sciences|December 1, 1975
Proceedings: Dissociation between subsets of murine T lymphocytes during ontogenesis and recovery from irradiationV Barak, E Israel, M Schlesinger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1995
Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancerD.Z. Edelmann, T. Peretz, V. Barak, et al.
Leukemia & Lymphoma|August 1, 1992
Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemiaV Barak, M Ginzburg, I Kalickman, et al.
Leukemia & Lymphoma|January 1, 1994
Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasiasD Engelhard, A Nagler, R Singer, et al.
Cytokines, Cellular & Molecular Therapy|January 14, 1998
Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignanciesA Toren, V Barak, D Novick, et al.
Leukemia Research|January 1, 1996
The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donorsR Condiotti, S Slavin, V Barak, et al.
Pageof 15

Showing results (21-30 of 148) with videos related to

Sort By:
Pageof 15
Journal of Hematotherapy|January 1, 1994
Treatment of chronic myelogenous leukemia with recombinant human interleukin-2 and interferon-alpha 2aA Nagler, A Ackerstein, V Barak, et al.
Cytokines, Cellular & Molecular Therapy|November 24, 1998
Dysregulation of inflammatory cytokines in unrelated bone marrow transplantationA Nagler, A Bishara, C Brautbar, et al.
The Annals of Otology, Rhinology, and Laryngology|August 26, 1998
Cytokine evaluation in throat infectionsE Deutsch, M Kaufman, B Nisman, et al.
Harefuah|January 15, 1991
[Clinical applicability of intraperitoneal administration of nutrients and drugs]I Roisman, Z Gimon, V Barak, et al.
Israel Journal of Medical Sciences|December 1, 1975
Proceedings: Dissociation between subsets of murine T lymphocytes during ontogenesis and recovery from irradiationV Barak, E Israel, M Schlesinger, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 1, 1995
Carboplatin and etoposide as first-line chemotherapy in advanced epithelial ovarian cancerD.Z. Edelmann, T. Peretz, V. Barak, et al.
Leukemia & Lymphoma|August 1, 1992
Serum soluble interleukin-2 receptor levels are associated with clinical disease status and histopathological grade in non-Hodgkin's lymphoma and chronic lymphocytic leukemiaV Barak, M Ginzburg, I Kalickman, et al.
Leukemia & Lymphoma|January 1, 1994
Soluble interleukin-2 receptor levels in cytomegalovirus disease and graft versus host disease after T-lymphocyte depleted bone marrow transplantation for hematological neoplasiasD Engelhard, A Nagler, R Singer, et al.
Cytokines, Cellular & Molecular Therapy|January 14, 1998
Soluble interferon-gamma receptor and interferon-gamma in patients undergoing allogeneic bone marrow transplantation for hematological malignanciesA Toren, V Barak, D Novick, et al.
Leukemia Research|January 1, 1996
The novel immunomodulator, Linomide, stimulates interleukin-2-induced human natural killer (NK) cell and PHA-stimulated T cell proliferation from normal donorsR Condiotti, S Slavin, V Barak, et al.
Pageof 15